Aurora Cannabis Inc. (NASDAQ:ACB - Free Report) - Roth Capital issued their Q1 2026 earnings estimates for Aurora Cannabis in a research report issued to clients and investors on Thursday, February 6th. Roth Capital analyst W. Kirk expects that the company will post earnings of $0.17 per share for the quarter. The consensus estimate for Aurora Cannabis' current full-year earnings is ($0.10) per share. Roth Capital also issued estimates for Aurora Cannabis' Q2 2026 earnings at $0.02 EPS, Q3 2026 earnings at $0.40 EPS and Q4 2026 earnings at $0.29 EPS.
Aurora Cannabis (NASDAQ:ACB - Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported $0.06 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $0.15. Aurora Cannabis had a return on equity of 0.59% and a net margin of 0.42%.
Other equities analysts also recently issued research reports about the stock. Atb Cap Markets raised shares of Aurora Cannabis from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, February 5th. TD Cowen initiated coverage on shares of Aurora Cannabis in a report on Wednesday, December 11th. They set a "buy" rating for the company. Finally, TD Securities upgraded shares of Aurora Cannabis to a "strong-buy" rating in a research report on Thursday, December 12th.
View Our Latest Analysis on Aurora Cannabis
Aurora Cannabis Price Performance
Shares of NASDAQ ACB traded up $0.59 during trading hours on Friday, hitting $6.62. 6,298,091 shares of the stock were exchanged, compared to its average volume of 4,714,810. The company's fifty day simple moving average is $4.27 and its two-hundred day simple moving average is $5.15. The company has a market cap of $363.06 million, a PE ratio of 132.03 and a beta of 1.84. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.88 and a current ratio of 3.30. Aurora Cannabis has a 1-year low of $2.84 and a 1-year high of $9.35.
Hedge Funds Weigh In On Aurora Cannabis
A number of institutional investors and hedge funds have recently modified their holdings of the business. SBI Securities Co. Ltd. bought a new position in Aurora Cannabis during the fourth quarter worth $31,000. Cubist Systematic Strategies LLC bought a new stake in shares of Aurora Cannabis during the second quarter valued at approximately $50,000. Wealthspire Advisors LLC acquired a new position in shares of Aurora Cannabis during the fourth quarter worth approximately $149,000. Finally, Tidal Investments LLC lifted its holdings in shares of Aurora Cannabis by 2.7% in the 3rd quarter. Tidal Investments LLC now owns 1,344,321 shares of the company's stock worth $7,905,000 after purchasing an additional 34,988 shares in the last quarter. 47.63% of the stock is currently owned by institutional investors.
About Aurora Cannabis
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
See Also
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
